Subscribe To
FRLN / New Strong Buy Stocks for July 14
FRLN News
By GlobeNewsWire
August 8, 2023
Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call
LONDON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that it will host a live conference call a more_horizontal
By GlobeNewsWire
July 31, 2023
Freeline to Participate in Upcoming Investor Conferences
LONDON, July 31, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that the company will be participating in more_horizontal
By Zacks Investment Research
July 14, 2023
New Strong Buy Stocks for July 14
LE, ING, PD, FRLN and SUNW have been added to the Zacks Rank #1 (Strong Buy) List on July 14, 2023. more_horizontal
By Zacks Investment Research
June 13, 2023
Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) witnesses a hammer chart pattern, indicating support found by the stock after losing some valu more_horizontal
By GlobeNewsWire
April 12, 2023
Freeline to Present at 22nd Annual Needham Virtual Healthcare Conference
LONDON, April 12, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its Chief Executive Officer Michae more_horizontal
By GlobeNewsWire
November 9, 2022
Freeline to Present at the Stifel Healthcare Conference
LONDON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that Chief Executive Officer Michael Parin more_horizontal
By GlobeNewsWire
May 2, 2022
Freeline To Present at the 25th Annual Meeting of the American Society of Gene and Cell Therapy
Five abstracts accepted with new research and technology insights and data to further enhance AAV-based gene therapy candidates Five abstracts accept more_horizontal